Skip to main content
All lobbying filings

CME GROUP, INC.

Lobbying for CME GROUP INC

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $430,000.00 expenses · posted Apr 16, 2025

Official filing document

 Bills named in this filing 3
 Lobbying activity 3
Agriculture

Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) (Title VII: Wall Street Transparency and Accountability); Issues related to regulation of clearinghouses, swap data repositories, swap execution facilities, and designated contract markets; Issues related to CFTC Funding; Issues related to Derivatives Clearing Market Structure; Issues related to CFTC Reauthorization; H.R. 4763 - Financial Innovation and Technology for the 21st Century Act (118th Congress) (issues related to Sec. 101 - Definitions under the Securities Act of 1933, Sec. 102 - Definitions under the Commodity Exchange Act, Sec. 103 - Definitions under this Act, Sec. 107 - Commodity Exchange Act savings provisions, and Section 401 - Commission jurisdiction over digital commodity transactions); Issues related to the Clearing of US Treasury futures.

Financial Institutions/Investments/Securities

Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) (Title II: Issues related to orderly liquidation authority and Title VIII: Payment Clearing and Settlement Supervision); Issues related to the regulation of systemically important financial market utilities; Issues related to Crypto Spot Market Regulation; S. 394 - GENIUS Act of 2025; H.R. 2392 - STABLE Act of 2025; Issues related to Basel III Bank Capital Standards; Issues related to the Clearing of US Treasury futures.

Taxation/Internal Revenue Code

Issues related to tax treatment of futures, securities, and commodities; Issues related to Sec. 1256 of the tax code related to the tax treatment of futures and options.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem